Skip to search formSkip to main contentSkip to account menu

bcr-abl peptide vaccine

Known as: bcr-abl vaccine 
A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune… 
National Institutes of Health

Related topics

Related topics

1 relation
Fusion Proteins, bcr-abl

Search for papers about bcr-abl peptide vaccine

Search papers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)